Skip to content

VDM PHARMACARE

Active
Private limited companyfounded 2025active for 1 yearHeiveld 76, 1745 Opwijk, BelgiumKBO/BCE: BE 1020.153.453

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

VDM PHARMACARE has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €26,824 and a net result of €27,057. Its solvency ranks better than 54% of 39,242 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
VDM PHARMACAREActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 19-02-2025 Normal situation
Legal form
Private limited company
Registered office
Heiveld 76, 1745 Opwijk
Activity
Activities of head offices NACE 70100
Establishment unit
2.370.761.558 1745 Opwijk, since 19-02-2025
Financial year end
31 December
Peppol
Reachable since 11-03-2025
Company details

Board and ownership

Board
Board & ownership

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€37,335
Turnover
≈ €110,000
estimated
Profit
€27,057
Equity
€26,824
Total assets
€44,484
2025 accounts filed 2 days before the deadline
Filed on 29-07-2026at the National Bank
Financials
Score breakdownraises riskFounded in 2025lowers riskSector: Activities of head offices; management consultancy activities (NACE 70)Liquidity: current ratio 2.52, cash €9,737Figures for financial year 2025 (filed on 29-07-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 63% of micro companies in head offices and management consultancy (NACE 70)
Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency 85
equity 60.3% of total assets
Liquidity 59
short-term debt 39.7% · cash 21.9%
Profitability 100
return on assets 60.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (48,516 companies, NACE 70, micro)
Last 24 months 03-2026: 0.4% 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026highest value 08-2026: < 0.1%▼ -0.4 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.52, above the usual 1.5. Short-term debt is 39.7% and cash 21.9% of total assets. 39.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 55% of them on solvency, 50% on liquidity and 84% on profitability.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Activities of head offices; management consultancy activities (NACE 70)
KBO
lowers risk · Liquidity: current ratio 2.52, cash €9,737
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 29-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
2 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about VDM PHARMACARE

What is the company number of VDM PHARMACARE?
The company number of VDM PHARMACARE is 1020.153.453. The VAT number is the same number with BE in front: BE 1020.153.453.
Where is VDM PHARMACARE based?
The registered office is at Heiveld 76, 1745 Opwijk.Company details
What does VDM PHARMACARE do?
According to the KBO register, the main activity is activities of head offices (NACE 70100).
What is the legal form of VDM PHARMACARE?
The legal form of VDM PHARMACARE is Private limited company (BV).
When was VDM PHARMACARE founded?
VDM PHARMACARE was founded on 19-02-2025.
Is VDM PHARMACARE still active?
Yes, VDM PHARMACARE is an active enterprise in the KBO register.
What is the turnover of VDM PHARMACARE?
The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €37,335 and 145 comparable companies (NACE 70). It probably lies between €63,000 and €150,000.Financials
Is VDM PHARMACARE profitable?
In financial year 2025, VDM PHARMACARE made a profit of €27,057.
Where can I find the annual accounts of VDM PHARMACARE?
VDM PHARMACARE filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank

Comparable companies

These companies have the same main activity as VDM PHARMACARE: activities of head offices (NACE 70100). They are comparable in size and age: total assets between €41,300 and €57,300, founded between 2024 and 2025.

CompanyTotal assetsGross margin
VDM PHARMACARE Opwijk€44,484€37,335
FASE 1 Zaventem€41,285€33,299
ARLANDRIA Steenokkerzeel€56,987€41,668
MJD PROJECTS Kapelle-op-den-Bos€57,328€42,429
Pointed Management Avelgem€50,747€38,150
JV Consul + Oostende€53,113€37,324
Ken's Company Brecht€47,364€40,825
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure